Country
Germany
Germany-based Affimed NV has priced its previously announced US offering of 12 million shares at $2.50 per common share. After deducting underwriting discounts, the net proceeds are expected to be about $28.2 million.
Full text available to subscribers only. Click here for information on subscribing to MedNous.